This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB03451/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03451/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03451/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03451/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03451
rdf:type
n3:Drug
n3:description
1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3 is a solid. This compound belongs to the vitamin D and derivatives class of chemicals. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. It is known to target the vitamin D3 receptor.
n3:group
experimental
owl:sameAs
n10:DB03451 n11:DB03451
dcterms:title
1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3
adms:identifier
n7:DB03451 n8:KH1 n12:46936681 n13:46505581
n3:IUPAC-Name
n4:271B496D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4973-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4972-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B496F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4970-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4971-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B496B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4969-363D-11E5-9242-09173F13E4C5 n4:271B496C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B496A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4979-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B497A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4974-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4975-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4977-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4976-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4978-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B497F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4981-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4982-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B497E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B497D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4980-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B496E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B497B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B497C-363D-11E5-9242-09173F13E4C5